INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
02/10/2026
Back to search
Official data from USPTO
IMMUNOSIGN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUNOSIGN
ST13
US500000079214190Class
5, 9, 10, 44
Filing
79214190
Registration
5572566
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
02/11/2026
Trademark type
Word
Nice classes
5, 9, 10, 44
Filing date
01/20/2017
Registration date
10/02/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/26/2024
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
Marseille, FR
Examiner
CROWLEY, SEAN MICHAEL
Current location
Historical data usage
Holders and representatives
Holders
Veracyte
HalioDx
HalioDx
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products being chemical or biological preparations for medical and pharmaceutical use for use in vitro testingfor use in the clinical diagnosticprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostic or identification of biological systems; biological reagents for pharmaceutical use for providing information on diagnostics or identification of biological systems
Class 9
Software for use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical conditionin the field of biology; application software in the nature of a mobile application for use in the clinical diagnosisprognosismonitoringprediction of response to treatments and on-going evaluationanalysis and study of a cancertumor or equivalent medical condition in the field of biology
Class 10
medical apparatus and instruments for providing information on diagnostics or identification of biological systemsgene expression analysis and markers detection devicesmedical testing devices and diagnostic apparatus for detectinganalyzing or assessing a cancertumor or equivalent medical condition; medical instruments for cell detection in the context of a cancertumor or equivalent medical condition
Class 44
Medical analysis services; medical assistance; health services; medical therapeutic services; medical diagnosticsdiagnostics in the field of medicine; genetic analysis services for medical purposesanalysis of a medical disordertumorcancer or equivalent medical condition
Publications
History of USPTO decisions and trademark events.
48 publications found
INPC
INVALIDATION PROCESSED
02/10/2026
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
08/26/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2025
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
12/26/2024
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
12/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/26/2024
ES75
TEAS SECTION 71 & 15 RECEIVED
05/22/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/02/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/01/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/15/2019
FIMP
FINAL DISPOSITION PROCESSED
01/14/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2018
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
07/17/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/17/2018
PUBO
PUBLISHED FOR OPPOSITION
07/17/2018
GPNX
NOTIFICATION PROCESSED BY IB
07/14/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/27/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/27/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2018
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
06/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2018
GNRT
NON-FINAL ACTION E-MAILED
04/05/2018
CNRT
NON-FINAL ACTION WRITTEN
04/05/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/28/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/28/2018
ALIE
ASSIGNED TO LIE
02/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/15/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/31/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/31/2018
RFNT
REFUSAL PROCESSED BY IB
09/15/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/25/2017
RFRR
REFUSAL PROCESSED BY MPU
08/25/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/24/2017
CNRT
NON-FINAL ACTION WRITTEN
08/23/2017
MAFR
APPLICATION FILING RECEIPT MAILED
08/22/2017
DOCK
ASSIGNED TO EXAMINER
08/16/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/16/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/10/2017
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOSIGN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.